This resolution recognizes the critical importance of equity, diversity, and inclusion in federally funded health research, asserting that these principles are necessary to enhance scientific excellence and ensure equitable outcomes for patients in the United States. It also commits to addressing systemic barriers in federally funded research projects that disproportionately affect underserved and underrepresented communities, such as bias in funding, publication, and representation. The resolution strongly opposes recent proposals, including a White House Office of Management and Budget rule, that would politicize the control of federal grants, de-emphasize peer review , and restrict research on diversity, equity, and inclusion . These proposed changes could also limit international collaborations, prohibit federal funding for publication costs, and allow for the termination of active grants without a clear appeal process, thereby undermining the framework for basic and applied research. Highlighting the historical underrepresentation of women and people of color in clinical trials and the resulting health disparities, the resolution underscores the need for research that reflects all populations. It urges the administration to maintain the longstanding, apolitical, science-backed peer review process to safeguard the integrity of U.S. health innovation and ensure that research effectively serves all Americans, regardless of background, gender, or socioeconomic status.